Picosecond laser applications in aesthetic dermatology
Abstract
Clinical trials have reported the efficacy and safety of PS lasers in the treatment of multicolored and recalcitrant tattoos.References
Sakamoto FH, Avram MM, Anderson RR. Lasers and other energy technologies principles and skin interactions. 3rd ed. In: Bolognia JL, Jorizzo JL, Schaffer JV, (editors). Dermatology. Spain: Mosby Elsevier; 2012. p. 2251–2253.
Zachary CB, Rofagha R. Laser therapy. 3rd ed. In Bolognia JL, Jorizzo JL, Schaffer JV (editors). Dermatology. Spain: Mosby Elsevier; 2012. p. 2267–2268.
Reiter O, Atzmony L, Akerman L, Levi A, Kershenovich R, et al. Picosecond lasers for tattoo removal: A systematic review. Lasers Med Sci 2016; 31(7): 1397–1405. doi: 10.1007/s10103-016-2001-0.
Brauer JA, Kazlouskaya V, Alabdulrazzaq H, Bae YS, Bernstein LJ, et al. Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring. JAMA Dermatol 2015; 151(3): 278–284. doi: 10.1001/jamadermatol.2014.3045.
Petersen H, Tavakoli F, Kruber S, Münscher A, Gliese A, et al. Comparative study of wound healing in rat skin following incision with a novel picosecond infrared laser (PIRL) and different surgical modalities. Lasers Surg Med 2016; 48(4): 385–391. doi: 10.1002/lsm.22498.
Ohshiro T, Ohshiro T, Sasaki K, Kishi K. Picosecond pulse duration laser treatment for dermal melanocytosis in Asians: A retrospective review. Laser Ther 2016; 25(2): 99–104. doi: 10.5978/islsm.16-OR-07.
Chan JC, Shek SY, Kono T, Yeung CK, Chan HH. A ret-rospective analysis on the management of pigmented le-sions using a picosecond 755-nm alexandrite laser in Asians. Lasers Surg Med 2016; 48(1): 23–29. doi: 10.1002/lsm.22443.
Weiss RA, McDaniel DH, Weiss MA, Mahoney AM, Beasley KL, et al. Safety and efficacy of a novel diffractive lens array using a picosecond 755 nm alexandrite laser for treatment of wrinkles. Lasers Surg Med 2017; 49(1): 40–44. doi: 10.1002/lsm.22577.
Copyright (c) 2017 Saki N.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher rights for the first publication with the work concurrently licensed under the Creative Commons Attribution-Noncommercial 4.0 International License
Under this license, author(s) will allow third parties to download, reuse, reprint, modify, distribute and/or copy the content under the condition that the authors are given credit and that the work is not used for commercial purposes. No permission is required from the authors or the publisher.
This broad license intends to facilitate free access, as well as the unrestricted use of original works of all types. This ensures that the published work is freely and openly available in perpetuity.
